Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (11-20 of 470) with videos related to

Pageof 47
Sort By:
Drugs|September 21, 2014
Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?Damien Gallagher, Nathan Herrmann
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Lifetime Alcohol Abuse in Institutionalized World War II VeteransNathan Herrmann, Goran Eryavec
Neurology|July 28, 2004
Donepezil therapy for neuropsychiatric symptoms in AD: methods make the messageNathan Herrmann, David Knopman
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 5, 2003
Old and homeless: a review and survey of older adults who use shelters in an urban settingVicky Stergiopoulos, Nathan Herrmann
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Buspirone in the Management of Agitation and Aggression Associated With DementiaNathan Herrmann, Goran Eryavec
Drug Safety|September 15, 2006
Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Nathan Herrmann, Krista L Lanctôt
Evidence-Based Mental Health|January 27, 2005
Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann
Lancet (London, England)|October 24, 2021
Mirtazapine for agitation in dementia: moving forwardKrista L Lanctôt, Nathan Herrmann
CNS Drugs|February 9, 2005
Do atypical antipsychotics cause stroke?Nathan Herrmann, Krista L Lanctôt
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 21, 2007
Pharmacologic management of neuropsychiatric symptoms of Alzheimer diseaseNathan Herrmann, Krista L Lanctôt
Pageof 47

Showing results (11-20 of 470) with videos related to

Sort By:
Pageof 47
Drugs|September 21, 2014
Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?Damien Gallagher, Nathan Herrmann
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Lifetime Alcohol Abuse in Institutionalized World War II VeteransNathan Herrmann, Goran Eryavec
Neurology|July 28, 2004
Donepezil therapy for neuropsychiatric symptoms in AD: methods make the messageNathan Herrmann, David Knopman
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 5, 2003
Old and homeless: a review and survey of older adults who use shelters in an urban settingVicky Stergiopoulos, Nathan Herrmann
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Buspirone in the Management of Agitation and Aggression Associated With DementiaNathan Herrmann, Goran Eryavec
Drug Safety|September 15, 2006
Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Nathan Herrmann, Krista L Lanctôt
Evidence-Based Mental Health|January 27, 2005
Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann
Lancet (London, England)|October 24, 2021
Mirtazapine for agitation in dementia: moving forwardKrista L Lanctôt, Nathan Herrmann
CNS Drugs|February 9, 2005
Do atypical antipsychotics cause stroke?Nathan Herrmann, Krista L Lanctôt
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 21, 2007
Pharmacologic management of neuropsychiatric symptoms of Alzheimer diseaseNathan Herrmann, Krista L Lanctôt
Pageof 47